World's Best Scientists 2026 revealed!
Segundo González

Segundo González

D-Index & Metrics

Immunology

D-Index
51
Citations
7890
World Ranking
4174
National Ranking
47

Segundo González publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Segundo González sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 146 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Segundo González D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Segundo González sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Segundo González is affiliated with the University of Oviedo in Spain. Their research primarily focuses on fields related to Medicine and Immunology and Microbiology, contributing notably to both areas with 33 and 21 publications respectively. Within these domains, their subfields of study include Immunology, Oncology, Molecular Biology, Pathology and Forensic Medicine, and Genetics.

The research topics Segundo González addresses encompass several important areas of biomedical science. These include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • T-cell and B-cell Immunology

Segundo González has contributed to multiple papers in prominent journals. Notable recent publications include:

  • "Chemo-Immunotherapy: A New Trend in Cancer Treatment" (2023) in Cancers
  • "Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer" (2020) in International Journal of Molecular Sciences
  • "LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia" (2021) in Cancers
  • "Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy" (2023) in Molecular Cancer
  • "Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance" (2020) in Molecular Cancer Therapeutics

The scientist frequently publishes in journals such as Cancers, Biomarker Research, Methods in Molecular Biology, International Journal of Molecular Sciences, and Molecular Cancer.

Frequent collaborators of Segundo González include Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, Ana Pilar González, and Candelaria Aguilar-García. These partnerships highlight ongoing efforts within collaborative research networks focusing on related biomedical topics.

Best Publications

  • Control of Metastasis by NK Cells

    Alejandro López-Soto;Segundo Gonzalez;Mark J. Smyth;Lorenzo Galluzzi;Lorenzo Galluzzi

  • Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands

    Brett K Kaiser;Daesong Yim;I-Ting Chow;Segundo Gonzalez;Segundo Gonzalez

  • NKG2D ligands: key targets of the immune response

    Segundo González;Alejandro López-Soto;Beatriz Suarez-Alvarez;Antonio López-Vázquez

  • Immunobiology of human NKG2D and its ligands.

    S González;V Groh;T Spies

  • HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis

    S. Gonzalez-Roces;M. V. Alvarez;S. Gonzalez;A. Dieye

  • The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.

    Segundo Gonzalez;J. Martinez‐Borra;J. C. Torre‐Alonso;S. Gonzalez‐Roces

  • Protective Effect of the HLA-Bw4I80 Epitope and the Killer Cell Immunoglobulin-Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection

    Antonio López-Vázquez;Luis Rodrigo;Jesús Martínez-Borra;Ramón Pérez

  • TNF-α −308A promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn’s patients with fistulizing disease

    Segundo González;Luis Rodrigo;Jesús Martínez-Borra;Antonio López-Vázquez

  • NKG2D signaling in cancer immunosurveillance

    Alejandro López-Soto;Leticia Huergo-Zapico;Andrea Acebes-Huerta;Mónica Villa-Alvarez

  • The NKG2D receptor: sensing stressed cells.

    Carlos López-Larrea;Beatriz Suárez-Alvarez;Alejandro López-Soto;Antonio López-Vázquez

  • High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn’s disease

    Jesús Martínez-Borra;Carlos López-Larrea;Segundo González;Dolores Fuentes

  • Chemo-Immunotherapy: A New Trend in Cancer Treatment

    Unknown

  • MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201

    A Lopez-Vazquez;L Rodrigo;D Fuentes;S Riestra

  • HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.

    A López-Soto;A R Folgueras;E Seto;S Gonzalez

  • Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population.

    Segundo González;Chaim Brautbar;J Martı́nez-Borra;A López-Vazquez

  • Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor

    Alejandro López-Soto;Leticia Huergo-Zapico;José Alberto Galván;Luis Rodrigo

  • New insights regarding HLA‐B27 diversity in the Asian population

    S. García‐Fernández;S. Gonzalez;A. Miña Blanco;J. Martinez‐Borra

  • 17β-Estradiol Activates Glucose Uptake via GLUT4 Translocation and PI3K/Akt Signaling Pathway in MCF-7 Cells

    Pablo Garrido;Javier Morán;Ana Alonso;Segundo González

  • Association of ankylosing spondylitis with HLA-B*1403 in a West African population.

    Carlos López-Larrea;Moustafa Mijiyawa;Segundo González;J. Luis Fernández-Morera

  • Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

    A. López-Vázquez;A. Miña-Blanco;J. Martínez-Borra;P.D. Njobvu

  • Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

    Ana P Gonzalez-Rodriguez;Juan Contesti;Leticia Huergo-Zapico;Alejandro Lopez-Soto

  • MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis.

    Segundo González;Jesús Martínez-Borra;Antonio López-Vázquez;Sonia García-Fernández

  • HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility.

    J Martinez-Borra;Segundo Gonzalez;A López-Vazquez;M.A Gelaz

Frequent Co-Authors

Carlos López-Larrea
Carlos López-Larrea Central University Hospital of Asturias
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Massimo Vitale
Massimo Vitale University of Genoa
Eliecer Coto
Eliecer Coto University of Oviedo
Chaim Brautbar
Chaim Brautbar Hebrew University of Jerusalem
Veronika Groh
Veronika Groh Fred Hutchinson Cancer Research Center
Claudia Cantoni
Claudia Cantoni University of Genoa
Guido Kroemer
Guido Kroemer Université Paris Cité
Thomas Spies
Thomas Spies Fred Hutchinson Cancer Research Center
Manuel S. Rodriguez
Manuel S. Rodriguez Centre national de la recherche scientifique, CNRS

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various interdisciplinary career options, especially in healthcare. One promising path is advancing your credentials as a nurse practitioner, which often complements immunology expertise. Many students explore the easiest nurse practitioner program options to balance rigorous coursework with practical experience.

Mental health is another critical field linked to immunology, especially in psychiatric care. Aspiring psychiatric nurse practitioners can benefit from enrolling in the best pmhnp programs, which emphasize clinical placement and hands-on training. For those mindful of costs, researching the cheapest pmhnp programs can make advanced education more accessible.

Outcomes in this sector are encouraging, with many professionals earning competitive salaries. For example, those who pursue higher degrees like the Doctor of Nursing Practice (DNP) can refer to the doctor of nursing practice salary data to understand financial prospects across different states. This insight aids in making informed career decisions within immunology-related fields.

Best Scientists Citing Segundo González

Trending Scientists

Recently Published Articles